Interestingly, in IIM-ILD, the presence of autoantibodies to TRIM21 disrupts immune homeostasis and is associated with poor prognosis, and the role played by TRIM21 antigens in the pathogenesis of IIM-ILD is also thought-provoking. This evidence concerns the gene TRIM21 and acquired idiopathic inflammatory myopathy.